Dare BioscienceDARE
13F holders, Q4 2025 (December 31)27holders +6
11new positions
4sold out
1famous investor
$1.93avg. 13F price*
At the end of Q4 2025, 27 institutions reported holding Dare Bioscience Inc. (DARE) in their 13F filings, up 6 from Q3 2025. 11 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.0M), Geode Capital Management, LLC ($229K) and Susquehanna International Group, LLP ($135K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Dare Bioscience Inc.
- CUSIP
- 23666P200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $254K |
| Exits | 4 | $34K |
All 13F filers, Q3 2025 → Q4 2025: 271,853 shares bought and 62,409 shares sold, net +209,444 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Vanguard Group Inc. | 0.00% | Add +32.5% | 523,053 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Reduce -3.8% | 118,655 | $229K |
| Susquehanna International Group, LLP | 0.00% | Add +16.3% | 70,021 | $135K |
| Two Sigma Investments, LP | 0.00% | New | 33,036 | $64K |
| State Street Corp. | 0.00% | No change | 23,515 | $45K |
| US Bancorp \de | 0.00% | New | 20,920 | $40K |
| UBS Group AG | 0.00% | Reduce -7.5% | 20,915 | $40K |
| Renaissance Technologies | 0.00% | Reduce -67.2% | 19,295 | $37K |
| Virtu Financial LLC | 0.00% | Add +8.2% | 19,200 | $37K |
| Two Sigma Advisers, LP | 0.00% | New | 17,900 | $35K |
| BlackRock, Inc. | 0.00% | No change | 16,971 | $33K |
| Northern Trust Corp. | 0.00% | Add +3.1% | 15,431 | $30K |
| Raymond James Financial Inc. | 0.00% | No change | 15,334 | $30K |
| LPL Financial LLC | 0.00% | New | 14,639 | $28K |
| XTX Topco Ltd | 0.00% | New | 10,983 | $21K |
| Objectivity Squared, LLC | 0.01% | New | 10,915 | $21K |
| Jane Street Group, LLC | 0.00% | New | 10,559 | $20K |
| HRT Financial LP | 0.00% | New | 10,497 | $20K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 10,222 | $20K |
| Parallel Advisors, LLC | 0.00% | New | 2,405 | $5K |
| IFS Advisors, LLC | 0.00% | No change | 950 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.2% | 575 | $1K |
| Bank of America Corp. | 0.00% | Reduce -1.5% | 129 | $250 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 110 | $212 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 17 | $33 |
| Inspire Investing, LLC | 0.00% | New | 12 | $23 |
| Cornerstone Planning Group LLC | 0.00% | Reduce -99.2% | 2 | $4 |
"% of holder's portfolio" is DARE's weight in each manager's 13F, not the share of Dare Bioscience Inc. the manager owns.